Cargando…

Antiangiogenic Effect of Platelet P2Y(12) Inhibitor in Ischemia-Induced Angiogenesis in Mice Hindlimb

PURPOSE: Postischemic inflammation induces angiogenesis, while platelet P2Y(12) inhibitors can alleviate this inflammation. Therefore, we studied the potential effects of P2Y(12) inhibitor, ticagrelor, on angiogenesis in a mouse model of hindlimb ischemia. METHODS: Laser Doppler perfusion imaging an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoli, Zhao, Huan, Yang, Naiquan, Jin, Yue, Chen, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052144/
https://www.ncbi.nlm.nih.gov/pubmed/33898623
http://dx.doi.org/10.1155/2021/5529431
Descripción
Sumario:PURPOSE: Postischemic inflammation induces angiogenesis, while platelet P2Y(12) inhibitors can alleviate this inflammation. Therefore, we studied the potential effects of P2Y(12) inhibitor, ticagrelor, on angiogenesis in a mouse model of hindlimb ischemia. METHODS: Laser Doppler perfusion imaging and capillary density measurement were used for angiogenesis quantified. Immunofluorescence was used to detect the level of CD31. The mice muscle was harvested for enzyme-linked immunosorbent (ELISA) assay of interleukin- (IL) 10 activity and Western blot determination of vascular endothelial growth factor (VEGF) production. RESULTS: Ischemic hindlimb angiogenesis was sharply decreased in IL-10(+/+) mice than IL-10(−/−) mice. Ticagrelor inhibited angiogenesis and blood reperfusion recovery significantly elevated the levels of IL-10 and decreased the expression of VEGF in the IL-10(+/+) mouse ischemic hindlimb, which were abolished in IL-10-deficient (IL-10(–/–)) C57BL/6J mice. CONCLUSION: The study underscores that the effect of ticagrelor antiangiogenic function is related with the higher IL-10 expression.